Temporary Mechanical Circulatory Support in Acute Heart Failure

Cardiogenic shock (CS) is a challenging syndrome, associated with significant morbidity and mortality. Although pharmacological therapies are successful and can successfully control this acute cardiac illness, some patients remain refractory to drugs. Therefore, a more aggressive treatment strategy...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Federica Jiritano, Valeria Lo Coco, Matteo Matteucci, Dario Fina, Anne Willers, Roberto Lorusso
Formato:	article
Lenguaje:	EN
Publicado:	Radcliffe Medical Media 2020
Materias:	Diseases of the circulatory (Cardiovascular) system RC666-701
Acceso en línea:	https://doaj.org/article/3528f83205154d24b35ef1d0d2ed0d27
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:3528f83205154d24b35ef1d0d2ed0d27
record_format	dspace
spelling	oai:doaj.org-article:3528f83205154d24b35ef1d0d2ed0d272021-12-04T16:02:32ZTemporary Mechanical Circulatory Support in Acute Heart Failure10.15420/cfr.2019.022057-75592057-7540https://doaj.org/article/3528f83205154d24b35ef1d0d2ed0d272020-03-01T00:00:00Zhttps://www.cfrjournal.com/articleindex/cfr.2019.02https://doaj.org/toc/2057-7540https://doaj.org/toc/2057-7559Cardiogenic shock (CS) is a challenging syndrome, associated with significant morbidity and mortality. Although pharmacological therapies are successful and can successfully control this acute cardiac illness, some patients remain refractory to drugs. Therefore, a more aggressive treatment strategy is needed. Temporary mechanical circulatory support (TCS) can be used to stabilise patients with decompensated heart failure. In the last two decades, the increased use of TCS has led to several kinds of devices becoming available. However, indications for TCS and device selection are part of a complex process. It is necessary to evaluate the severity of CS, any early and prompt haemodynamic resuscitation, prior TCS, specific patient risk factors, technical limitations and adequacy of resources and training, as well as an assessment of whether care would be futile. This article examines options for commonly used TCS devices, including intra-aortic balloon pumps, a pulsatile percutaneous ventricular assist device (the iVAC), veno-arterial extra-corporeal membrane oxygenation and Impella (Abiomed) and TandemHeart (LivaNova) percutaneous ventricular assist device.Federica JiritanoValeria Lo CocoMatteo MatteucciDario FinaAnne WillersRoberto LorussoRadcliffe Medical MediaarticleDiseases of the circulatory (Cardiovascular) systemRC666-701ENCardiac Failure Review , Vol 6, Iss , Pp - (2020)
institution	DOAJ
collection	DOAJ
language	EN
topic	Diseases of the circulatory (Cardiovascular) system RC666-701
spellingShingle	Diseases of the circulatory (Cardiovascular) system RC666-701 Federica Jiritano Valeria Lo Coco Matteo Matteucci Dario Fina Anne Willers Roberto Lorusso Temporary Mechanical Circulatory Support in Acute Heart Failure
description	Cardiogenic shock (CS) is a challenging syndrome, associated with significant morbidity and mortality. Although pharmacological therapies are successful and can successfully control this acute cardiac illness, some patients remain refractory to drugs. Therefore, a more aggressive treatment strategy is needed. Temporary mechanical circulatory support (TCS) can be used to stabilise patients with decompensated heart failure. In the last two decades, the increased use of TCS has led to several kinds of devices becoming available. However, indications for TCS and device selection are part of a complex process. It is necessary to evaluate the severity of CS, any early and prompt haemodynamic resuscitation, prior TCS, specific patient risk factors, technical limitations and adequacy of resources and training, as well as an assessment of whether care would be futile. This article examines options for commonly used TCS devices, including intra-aortic balloon pumps, a pulsatile percutaneous ventricular assist device (the iVAC), veno-arterial extra-corporeal membrane oxygenation and Impella (Abiomed) and TandemHeart (LivaNova) percutaneous ventricular assist device.
format	article
author	Federica Jiritano Valeria Lo Coco Matteo Matteucci Dario Fina Anne Willers Roberto Lorusso
author_facet	Federica Jiritano Valeria Lo Coco Matteo Matteucci Dario Fina Anne Willers Roberto Lorusso
author_sort	Federica Jiritano
title	Temporary Mechanical Circulatory Support in Acute Heart Failure
title_short	Temporary Mechanical Circulatory Support in Acute Heart Failure
title_full	Temporary Mechanical Circulatory Support in Acute Heart Failure
title_fullStr	Temporary Mechanical Circulatory Support in Acute Heart Failure
title_full_unstemmed	Temporary Mechanical Circulatory Support in Acute Heart Failure
title_sort	temporary mechanical circulatory support in acute heart failure
publisher	Radcliffe Medical Media
publishDate	2020
url	https://doaj.org/article/3528f83205154d24b35ef1d0d2ed0d27
work_keys_str_mv	AT federicajiritano temporarymechanicalcirculatorysupportinacuteheartfailure AT valerialococo temporarymechanicalcirculatorysupportinacuteheartfailure AT matteomatteucci temporarymechanicalcirculatorysupportinacuteheartfailure AT dariofina temporarymechanicalcirculatorysupportinacuteheartfailure AT annewillers temporarymechanicalcirculatorysupportinacuteheartfailure AT robertolorusso temporarymechanicalcirculatorysupportinacuteheartfailure
_version_	1718372725994553344

Temporary Mechanical Circulatory Support in Acute Heart Failure

Ejemplares similares